22 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
5
2, 4-diaminopyrimidine derivative and application thereof

Shanghai Zheye Biotechnology Co.
13
Substituted nucleosides and nucleotides for treating viral infections

Emory University
30
Nitrogen-containing polycyclic fused ring compound, pharmaceutical composition thereof, preparation method therefor and use thereof

Applied Pharmaceutical Science
12
HETEROARYL DERIVATIVE COMPOUNDS, AND USES THEREOF

Voronoi
48
INHIBITORS OF THE ONCOGENIC SHP2 PHOSPHATASE AND USES THEREOF

Sanford Burnham Prebys Medical Discovery Institute
81
BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER

Hoffmann-La Roche
2
COMPOUND SERVING AS NLRP3 INHIBITOR

Hangzhou Innogate Pharma
9
A NEW MOLECULAR SCAFFOLD FOR TARGETING HRPN13

Department of Health And Human Service
15
INHIBITORS AND DEGRADERS OF JANUS KINASE 2

H. Lee Moffitt Cancer Center and Research Institute
44
Carboxylic acid, acyl sulfonamide and acyl sulfamide-derivatized bicyclic aza-heteroaromatics as selective Mcl-1 inhibitors and as dual Mcl-1/Bcl-2 inhibitors

University of Maryland, Baltimore
111
Substituted 4-phenylpiperidines, their preparation and use

Columbia University
246
Human plasma kallikrein inhibitors

Biocryst Pharmaceuticals
32
Alpha-D-galactoside inhibitors of galectins

Galecto Biotech
62
Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors

Xenon Pharmaceuticals
40
Pyrimidine derivative and use thereof

Hubei Bio-Pharmaceutical Industrial Technological Institute
7
Compounds

Respivert
13
Discovery of selective protein arginine methyltransferase 5 inhibitors and biological evaluations.

Sichuan University
53
Agent for treatment of eye diseases

Daito Chemix
11
Mechanism of MenE inhibition by acyl-adenylate analogues and discovery of novel antibacterial agents.

Argonne National Laboratory
14
Aryloxmethyl cyclopropane derivatives as PDE10 inhibitors

Merck Sharp & Dohme
26
Fused tricyclic dual inhibitors of CDK 4/6 and FLT3

Amgen
8
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Merck Sharpe & Dohme